[Gene cloning of human dopaminergic D3 receptor and identification of its chromosome].

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 2129115)

Published in C R Acad Sci III on January 01, 1990

Authors

B Giros1, M P Martres, P Sokoloff, J C Schwartz

Author Affiliations

1: Unité de Neurobiologie et Pharmacologie (U.n. 109) de l'I.N.S.E.R.M., Centre Paul-Broca, Paris.

Articles citing this

The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev (2005) 1.80

Dopamine receptor genes: new tools for molecular psychiatry. J Psychiatry Neurosci (1992) 1.53

Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal models. J Med Chem (2010) 1.53

Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc Natl Acad Sci U S A (1991) 1.05

Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc Natl Acad Sci U S A (1993) 1.03

Structure-activity relationship study of N⁶-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization. J Med Chem (2012) 0.93

Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44. Pharmacol Biochem Behav (2009) 0.93

The N-terminal region of the dopamine D2 receptor, a rhodopsin-like GPCR, regulates correct integration into the plasma membrane and endocytic routes. Br J Pharmacol (2012) 0.90

Coupling of dopamine receptors to G proteins: studies with chimeric D2/D3 dopamine receptors. Cell Mol Neurobiol (2002) 0.88

A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride. CNS Neurosci Ther (2008) 0.87

Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol: effect on affinity and selectivity for dopamine D3 receptor. Bioorg Med Chem (2009) 0.85

Differential expression of autoreceptors in the ascending dopamine systems of the human brain. Proc Natl Acad Sci U S A (1994) 0.81

Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: impact on functional activity and selectivity for dopamine D2/D3 receptors. Bioorg Med Chem (2013) 0.80

Structural modifications of neuroprotective anti-Parkinsonian (-)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent molecule. J Med Chem (2014) 0.79

Novel roles for β-arrestins in the regulation of pharmacological sequestration to predict agonist-induced desensitization of dopamine D3 receptors. Br J Pharmacol (2013) 0.79

Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. Am J Hum Genet (1993) 0.78

Neuropharmacology of dopamine receptors:: Implications in neuropsychiatric diseases. J Sci Res Med Sci (2001) 0.78

Characterization of [(3) H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand. J Neurochem (2014) 0.77

Interaction of D₃ preferring agonist (-)-N⁶-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264) with cloned human D₂L, D₂S, and D₃ receptors: potent stimulation of mitogen-activated protein kinases and G protein-coupled inward rectifier potassium channels. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.75

G protein-coupled receptor kinases as regulators of dopamine receptor functions. Pharmacol Res (2016) 0.75

Understanding the Structural Requirements of Hybrid (S)-6-((2-(4-Phenylpiperazin-1-yl)ethyl)(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol and its Analogs as D2/D3 Receptor Ligands: A Three-Dimensional Quantitative Structure-Activity Relationship (3D QSAR) Investigation. Medchemcomm (2014) 0.75

In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors. Br J Pharmacol (1996) 0.75

Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds. Cell Signal (2017) 0.75

Articles by these authors

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature (1990) 6.18

Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (1994) 5.70

Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature (1983) 4.24

Highly potent and selective ligands for histamine H3-receptors. Nature (1987) 2.90

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature (1999) 2.89

International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev (1997) 2.71

Histaminergic mechanisms in brain. Annu Rev Pharmacol Toxicol (1977) 2.38

Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet (1992) 2.32

Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res (1991) 2.21

The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature (1980) 2.13

Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature (1990) 2.04

Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci U S A (1993) 1.98

High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature (1978) 1.87

Novel dopamine receptors half a decade later. Trends Pharmacol Sci (1995) 1.86

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature (2001) 1.84

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci U S A (1992) 1.76

Cloning and cerebral expression of the guinea pig histamine H3 receptor: evidence for two isoforms. Neuroreport (2000) 1.62

High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature (2000) 1.60

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol (1992) 1.57

Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology (Berl) (1976) 1.57

Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci (2000) 1.55

Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature (1975) 1.54

Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science (2000) 1.45

Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction. Cardiovasc Res (1999) 1.40

Histamine as a neurotransmitter in mammalian brain: neurochemical evidence. J Neurochem (1980) 1.40

Autoregulation of histamine release in brain by presynaptic H3-receptors. Neuroscience (1985) 1.39

Minireview: histamine receptors in brain. Life Sci (1979) 1.37

Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res (1999) 1.37

Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors. Neuroscience (1987) 1.30

Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Res (1990) 1.29

A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas. Neuroscience (1993) 1.29

Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci (2000) 1.29

Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase ("enkephalinase") as neuropeptidase. Life Sci (1981) 1.29

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci U S A (1997) 1.28

A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun (1993) 1.27

Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature (1991) 1.26

Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol (1985) 1.24

S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. J Pharmacol Exp Ther (1992) 1.22

Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience (1995) 1.21

Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies. J Neurochem (1980) 1.21

Histamine H3-receptors inhibit cholinergic neurotransmission in guinea-pig airways. Br J Pharmacol (1989) 1.18

D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res (1998) 1.17

A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride. Neuroscience (1987) 1.16

H3-receptors control histamine release in human brain. J Neurochem (1988) 1.15

Properties and regional distribution of histidine decarboxylase in rat brain. J Neurochem (1970) 1.15

Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain. Br J Pharmacol (2000) 1.12

Pharmacological characterization of histamine receptors mediating the stimulation of cyclic AMP accumulation in slices from guinea-pig hippocampus. Mol Pharmacol (1978) 1.12

Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor. Proc Natl Acad Sci U S A (1995) 1.10

A serine to glycine substitution at position 9 in the extracellular N-terminal part of the dopamine D3 receptor protein: no role in the genetic predisposition to bipolar affective disorder. Psychiatry Res (1993) 1.10

Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea. Gut (1992) 1.09

Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res (1997) 1.09

H1 and H2 receptors in the histamine-induced accumulation of cyclic AMP in guinea pig brain slices. Nature (1975) 1.09

Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zinc-metallohydrolases. Biochem Biophys Res Commun (1989) 1.09

Characterization and inhibition of a cholecystokinin-inactivating serine peptidase. Nature (1996) 1.09

Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats. Eur J Neurosci (2000) 1.08

Localization and function of the D3 dopamine receptor. Arzneimittelforschung (1992) 1.06

Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. Eur J Pharmacol (1999) 1.05

Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations. Eur J Pharmacol (1990) 1.05

Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. Eur J Pharmacol (1994) 1.05

In vivo occupation of cerebral histamine H1-receptors evaluated with 3H-mepyramine may predict sedative properties of psychotropic drugs. Eur J Pharmacol (1979) 1.04

Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol Psychiatry (2000) 1.04

Properties of "enkephalinase" from rat kidney: comparison of dipeptidyl-carboxypeptidase and endopeptidase activities. Biochem Biophys Res Commun (1982) 1.03

Cloning of OL1, a putative olfactory receptor and its expression in the developing rat heart. Receptors Channels (1995) 1.03

Distribution of enkephalinase (membrane metalloendopeptidase, E.C. 3.4.24.11) in rat organs. Detection using a monoclonal antibody. Lab Invest (1988) 1.03

A functional test identifies dopamine agonists selective for D3 versus D2 receptors. Neuroreport (1995) 1.03

A detailed mapping of histamine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine. Neuroscience (1988) 1.03

The third dopamine receptor (D3) as a novel target for antipsychotics. Biochem Pharmacol (1992) 1.03

Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand. Science (1985) 1.02